Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi
- 28 November 2006
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 20 (18), 2355-2360
- https://doi.org/10.1097/qad.0b013e32801086b0
Abstract
Objectives: Among adults started on antiretroviral treatment (ART) in a rural district hospital (a) to determine the cumulative proportion of deaths that occur within 3 and 6 months of starting ART, and (b) to identify risk factors that may be associated with such mortality. Design and setting: A cross-sectional analytical study set in Thyolo district, Malawi. Methods: Over a 2-year period (April 2003 to April 2005) mortality within the first 3 and 6 months of starting ART was determined and risk factors were examined. Results: A total of 1507 individuals (517 men and 990 women), whose median age was 35 years were included in the study. There were a total of 190 (12.6%) deaths on ART of which 116 (61%) occurred within the first 3 months (very early mortality) and 150 (79%) during the first 6 months of initiating ART. Significant risk factors associated with such mortality included WHO stage IV disease, a baseline CD4 cell count under 50 cells/μl and increasing grades of malnutrition. A linear trend in mortality was observed with increasing grades of malnutrition (χ2 for trend = 96.1, P ≤ 0.001) and decreasing CD4 cell counts (χ2 for trend = 72.4, P ≤ 0.001). Individuals who were severely malnourished [body mass index (BMI) < 16.0 kg/m2] had a six times higher risk of dying in the first 3 months than those with a normal nutritional status. Conclusions: Among individuals starting ART, the BMI and clinical staging could be important screening tools for use to identify and target individuals who, despite ART, are still at a high risk of early death.Keywords
This publication has 15 references indexed in Scilit:
- Scaling up antiretroviral treatment in resource-poor settingsThe Lancet, 2006
- Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countriesThe Lancet, 2006
- How can the community contribute in the fight against HIV/AIDS and tuberculosis? An example from a rural district in MalawiTransactions of the Royal Society of Tropical Medicine and Hygiene, 2006
- Targeting CD4 testing to a clinical subgroup of patients could limit unnecessary CD4 measurements, premature antiretroviral treatment and costs in Thyolo District, MalawiTransactions of the Royal Society of Tropical Medicine and Hygiene, 2006
- Monitoring the response to antiretroviral therapy in resource-poor settings: the Malawi modelTransactions of the Royal Society of Tropical Medicine and Hygiene, 2004
- Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South AfricaAIDS, 2004
- Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studiesThe Lancet, 2002
- Bacteraemia and Mortality Among Adult Medical Admissions in Malawi – Predominance of Non-typhi Salmonellae andStreptococcus pneumoniaeJournal of Infection, 2001
- Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 1998
- Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, KenyaThe Lancet, 1990